Dispel These Myths to Maximize Value in Small and Midsize Biopharma M&A
Acquirers need to plan their integrations carefully and act quickly, but too often they delay decision making and destroy value.
Acquirers need to plan their integrations carefully and act quickly, but too often they delay decision making and destroy value.
Lilly’s Dave Ricks is passionate about diversity and inclusion at a crucial time.
These essential actions weave digital capabilities into each phase of the launch journey.
Quantum computing has the potential to significantly accelerate, enhance the quality of, and reduce the costs of drug discovery.
With advances in knowledge, understanding, technology, and data come fragmentation and complexity. Since the bets are big, companies need to evaluate prospects and make their investments count.
Teams often struggle to execute external licensing agreements and M&A transactions that can supplement internal innovation and revenue. Six factors can enhance performance.
Open-market business models—including exchanges, platforms, and hybrids—can transform the US health care industry, leading to more efficient, convenient, and cost-effective care.
Champions that want to keep their advantage—and laggards that want to make up some ground—can take three no-regret moves to create value for patients, shareholders, and society as a whole.
With the right strategic thinking, health care systems will finally succeed in delivering the benefits that consumers have come to expect from other industries.
Organizations must build on the momentum from their response to the crisis, delivering better care at lower overall cost and becoming more resilient to future disruptions.
The health systems that gain the most resilience and agility emerging from the crisis will be those that permanently change the way they work.
A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.
As the current crisis demonstrates, biopharma and medtech companies need to safeguard their networks against unanticipated disruptions. Here’s how.
Industry leaders set themselves apart with five key practices.
The medtech industry is poised for strong growth but faces challenges too. For private equity investors, making sense of the market requires understanding the range of investment themes.
BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.
